K250754

Substantially Equivalent

cmAngio® (V1.6)

Applicant: Curemetrix, Inc.
Product code: QIH
Advisory panel: Radiology
Date received: 2025-03-12
Decision date: 2025-04-10
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.